{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T17:02:32Z","timestamp":1772211752852,"version":"3.50.1"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"abbott"},{"name":"abbott"},{"name":"harzklinikum dorothea christiane erxleben gmbh"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"\n Aims<\/jats:title>\n To evaluate factors influencing the length of stay in patients undergoing percutaneous left atrial appendage occlusion (LAAO).<\/jats:p>\n <\/jats:sec>\n \n Methods and results<\/jats:title>\n \n Patient characteristics, procedural data and the occurrence of serious adverse events were analyzed from the Amplatzer\n TM<\/jats:sup>\n Amulet\n TM<\/jats:sup>\n Occluder Observational Study. Patients were divided into three groups: same day (S, 0day, n = 60, 5.6%) early (E, 1day, n = 526, 48.9%), regular (R, 2-3days, n = 338, 31.4%) and late (L, \u22654days, n = 152, 14.1%) discharge and followed up for 60 days. Procedure and device related SAE during the in-hospital stay (S: 0.0% vs. E: 1.0% vs. R: 2.1% vs. L: 23%, p<0.0001) were a major trigger for a prolonged in-hospital stay. Of the 37 subjects in the late discharge group with an SAE prior to discharge, cardiac or bleeding complications were the most common underlying conditions, occurring in 26 subjects. Multinomial logistic analysis only identified HAS-BLED score as an independent influencing factor (p = 0.04) for a late discharge. After 60 days, mortality tended to be greatest in the late discharge group (S: 0.0% vs. E: 1.0% vs. R: 1.2% vs. L: 3.3%, p = 0.1066).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Over half of the subjects receiving an Amplatzer Amulet occluder were discharged within 1 day of the implant procedure. Serious adverse events were a major trigger for a late discharge after LAAO. Increased HAS-BLED score was associated with a prolonged in-hospital stay.<\/jats:p>\n <\/jats:sec>","DOI":"10.1371\/journal.pone.0255721","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T13:27:36Z","timestamp":1628602056000},"page":"e0255721","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Length of stay following percutaneous left atrial appendage occlusion: Data from the prospective, multicenter Amplatzer Amulet Occluder Observational Study"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9746-7592","authenticated-orcid":true,"given":"Kerstin","family":"Piayda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shazia","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Erik","family":"Nielsen-Kudsk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizio","family":"Mazzone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Berti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juha","family":"Lund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Montorfano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hildick-Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Gage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4517-0068","authenticated-orcid":true,"given":"Tobias","family":"Zeus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,8,10]]},"reference":[{"issue":"8","key":"pone.0255721.ref001","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study","volume":"129","author":"SS Chugh","year":"2014","journal-title":"Circulation"},{"issue":"1","key":"pone.0255721.ref002","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.gheart.2014.01.004","article-title":"Global burden of atrial fibrillation in developed and developing nations","volume":"9","author":"SS Chugh","year":"2014","journal-title":"Glob Heart"},{"issue":"2","key":"pone.0255721.ref003","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence","volume":"114","author":"Y Miyasaka","year":"2006","journal-title":"Circulation"},{"issue":"8","key":"pone.0255721.ref004","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study","volume":"27","author":"J Heeringa","year":"2006","journal-title":"Eur Heart J"},{"issue":"4","key":"pone.0255721.ref005","doi-asserted-by":"crossref","DOI":"10.4103\/1658-5127.171993","article-title":"The new, direct, target-specific oral anticoagulants","volume":"6","author":"N Kassim","year":"2015","journal-title":"Journal of Applied Hematology"},{"issue":"5","key":"pone.0255721.ref006","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).","volume":"42","author":"G Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"24","key":"pone.0255721.ref007","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials","volume":"70","author":"VY Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"38","key":"pone.0255721.ref008","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"P Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"9689","key":"pone.0255721.ref009","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"DR Holmes","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"pone.0255721.ref010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"DR, Jr Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"pone.0255721.ref011","doi-asserted-by":"crossref","first-page":"867","DOI":"10.4244\/EIJ-D-17-00493","article-title":"Left atrial appendage occlusion with the AMPLATZER Amulet device: periprocedural and early clinical\/echocardiographic data from a global prospective observational study","volume":"13","author":"U Landmesser","year":"2017","journal-title":"EuroIntervention"},{"key":"pone.0255721.ref012","article-title":"Operator experience and outcomes after transcatheter left atrial appendage occlusion with the watchman device.","author":"AC Sawant","year":"2019","journal-title":"Cardiovasc Revasc Med"},{"issue":"4","key":"pone.0255721.ref013","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/CIRCULATIONAHA.110.976449","article-title":"Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry","volume":"123","author":"VY Reddy","year":"2011","journal-title":"Circulation"},{"issue":"8","key":"pone.0255721.ref014","first-page":"212","article-title":"Left Atrial Appendage Occlusion as Adjunctive Therapy to Anticoagulation for Stroke Recurrence","volume":"31","author":"X Freixa","year":"2019","journal-title":"J Invasive Cardiol"},{"issue":"17","key":"pone.0255721.ref015","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.4244\/EIJ-D-17-00672","article-title":"Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study","volume":"13","author":"MW Bergmann","year":"2018","journal-title":"EuroIntervention"},{"issue":"12","key":"pone.0255721.ref016","first-page":"869","article-title":"Left atrial appendage occlusion: rationale, evidence, devices, and patient selection","volume":"38","author":"JP Piccini","year":"2017","journal-title":"Eur Heart J"},{"issue":"7","key":"pone.0255721.ref017","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/ccd.27791","article-title":"Day-case percutaneous left atrial appendage occlusion-Safety and efficacy","volume":"92","author":"T Williams","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"pone.0255721.ref018","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ccd.26805","article-title":"Intracardiac versus transesophageal echocardiography for left atrial appendage occlusion with watchman","volume":"90","author":"AH Frangieh","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"pone.0255721.ref019","article-title":"Safety and Feasibility of Same-Day Discharge after Left Atrial Appendage Closure","author":"TS Gilhofer","year":"2020","journal-title":"Canadian Journal of Cardiology"},{"issue":"2","key":"pone.0255721.ref020","first-page":"243","article-title":"Incidence, Prevention, and Management of Periprocedural Complications of Left Atrial Appendage Occlusion","volume":"7","author":"J Thakkar","year":"2018","journal-title":"Interv Cardiol Clin"},{"issue":"9","key":"pone.0255721.ref021","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.hrthm.2017.05.038","article-title":"Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial","volume":"14","author":"LV Boersma","year":"2017","journal-title":"Heart Rhythm"},{"issue":"10","key":"pone.0255721.ref022","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.4244\/EIJY15M01_06","article-title":"Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug","volume":"11","author":"A Tzikas","year":"2016","journal-title":"EuroIntervention"},{"issue":"6","key":"pone.0255721.ref023","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/hrt.73.6.527","article-title":"Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment","volume":"73","author":"GY Lip","year":"1995","journal-title":"Br Heart J"},{"issue":"5","key":"pone.0255721.ref024","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"R Pisters","year":"2010","journal-title":"Chest"},{"issue":"4","key":"pone.0255721.ref025","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/CIRCINTERVENTIONS.112.968792","article-title":"Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?","volume":"5","author":"JM Ruiz-Nodar","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"issue":"4","key":"pone.0255721.ref026","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.amjcard.2015.05.015","article-title":"Impact of the HAS-BLED Score on Long-Term Outcomes After Percutaneous Coronary Intervention.","volume":"116","author":"H Konishi","year":"2015","journal-title":"Am J Cardiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0255721","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T13:34:08Z","timestamp":1628602448000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0255721"}},"subtitle":[],"editor":[{"given":"Giuseppe","family":"And\u00f2","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,8,10]]},"references-count":26,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0255721","relation":{"has-review":[{"id-type":"doi","id":"10.32388\/ZXTOUG","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,10]]}}}